EyePoint Pharmaceuticals (EYPT) Names David Price as CFO

August 1, 2018 7:14 AM UTC Send to a Friend
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) today announced the appointment of David Price as Chief Financial Officer, effective immediately. In this ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login